This article compiles and summarizes the latest developments in cosmetics regulations as of February 2026, including domestic China industry news, newly issued regulations, updates to relevant standards and policies, and regulatory requirements, as well as global regulatory trends in the cosmetics sector. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.

Recently, the Beijing Cosmetics Review and Inspection Center has published a series of Q&A regarding ordinary cosmetics filing. The following content is primarily excerpted from the 53rd issue, compiled by CIRS Group for reference.

On February 12, 2026, Indonesia submitted notification G/TBT/N/IDN/184 to the World Trade Organization (WTO), detailing the draft regulation regarding the Form and Procedures for the Labelling of Non-Halal Information. This initiative introduces uniform standards for the labeling of “Non-Halal”, ensuring consistency across products marketed within Indonesia. The deadline for comments is set for March 14, 2026.

On February 23, 2026, the Korea Cosmetics Association (KCIA) announced plans to amend the Cosmetics Act. Proposed by Assemblyman Kim Ki-woong, this amendment aims to regulate the accuracy of information in cosmetics labels and advertisements, ensuring that claims about the environmental characteristics or efficacy of cosmetics and their containers and packaging (such as biodegradability) comply with standards set by relevant international organizations or the Prime Minister's orders. The KCA is currently seeking public feedback, with the deadline for submissions set for February 27, 2026.

On 10 February 2026, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued final opinion (SCCS/1686/25) on the safety of Thiomersal (CAS No 54-64-8) and Phenylmercuric salts (CAS No 62-38-4, 94-43-9) as preservatives in cosmetic products.

What the Year of the Horse can teach businesses about speed, endurance, and discipline in today’s evolving regulatory landscape.

On January 27, 2026, the Indonesian Food and Drug Authority (BPOM) published the draft list of pharmaceutical ingredients used in natural medicines, health supplements, quasi-drugs, and certain cosmetics to implement the regulation on risk assessment for the use of ingredients in these products. The public consultation period has ended as of February 10, 2026.

To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in January 2026. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.

On February 2, 2026, the Taiwan Food and Drug Administration (TFDA), under the Ministry of Health and Welfare, announced a revision to the annex of the Documentation Required for Case-by-Case Review of Applications for the Use of Human Cell-Derived Exosomes in Cosmetics. The revised annex takes effect immediately upon the date of announcement.

In January 2026, China’s National Medical Products Administration (NMPA), along with the Shandong and Guangdong Provincial Medical Products Administrations, successively issued public notices on the regulatory sampling and testing of cosmetics. A total of 61 batches of products were found to be non-compliant with relevant regulations. In addition, the Jiangxi and Shandong Provincial Medical Products Administrations released inspection reports on cosmetic manufacturers, identifying 33 enterprises with regulatory issues.